Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | DRD5 | P21918 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367878 | 0.88 | MAOA (0.46) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL7209204 | 0.87 | MAOA (0.44) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL6876165 | 0.82 | MAOA (0.40) | MAOAMAOBMAPKAPK2ACSL1SRC | |
| SCHEMBL5344044 | 0.82 | MAOA (0.57) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL29934406 | 0.79 | MAOA (0.53) | MAOAMAOBMAPKAPK2DRD2DRD1 | |
| SCHEMBL5754978 | 0.79 | MAOA (0.53) | MAOAMAOBMAPKAPK2DRD2DRD1 | |
| SCHEMBL2715642 | 0.78 | MAOA (0.48) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL22205158 | 0.78 | MAOA (0.48) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL1581695 | 0.78 | MAOA (0.48) | MAOAMAOBMAPKAPK2GAANPSR1 | |
| SCHEMBL9274021 | 0.76 | MAOA (0.50) | MAOAMAOBMAPKAPK2GAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122326-A1 | RAZOR COMPRISING A MOLDED SHAVING AID COMPOSITION COMPRISING A THERMALLY RESILIENT SENSATE | The Gillette Company LLC (US) | 2017-02-01 | — | — | EP | claimed |
| WO-2015148309-A1 | RAZOR COMPRISING A MOLDED SHAVING AID COMPOSITION COMPRISING A THERMALLY RESILIENT SENSATE | THE GILLETTE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| EP-1147765-B1 | New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics | SEPPIC SA (FR) | 2006-05-03 | — | — | EP | claimed |
| US-7025955-B2 | Method for maximizing scalp health and inducing enhanced visual and tactile hair quality | SHAKLEE CORPORATION (US) | 2006-04-11 | — | — | US | claimed |
| WO-2004010958-A2 | A METHOD FOR MAXIMIZING SCALP HEALTH AND INDUCING ENHANCED VISUAL AND TACTILE HAIR QUALITY | SHAKLEE CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-20030185784-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven nonwoven supports | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2003-10-02 | — | — | US | claimed |
| US-20020006906-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES | 2002-01-17 | — | — | US | claimed |
| EP-1147765-A1 | New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) | 2001-10-24 | — | — | EP | claimed |
| EP-4103287-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS AND COOLING AGENTS | Symrise AG (DE) | 2022-12-21 | — | — | EP | disclosed |
| WO-2022122903-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS AND COOLING AGENTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| US-20210069094-A1 | HAIR CARE COMPOSITIONS | MELALEUCA, INC. | 2021-03-11 | — | — | US | disclosed |
| EP-3641724-A1 | NOVEL SURFACTANT MIXTURE, NOVEL COMPOSITION COMPRISING SAME AND USE THEREOF IN COSMETICS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2020-04-29 | — | — | EP | disclosed |
| US-10334929-B2 | Hair product application device | The Pro-Motion Group, LLC (US) | 2019-07-02 | — | — | US | disclosed |
| WO-2018234648-A1 | NOVEL SURFACTANT MIXTURE, NOVEL COMPOSITION COMPRISING SAME AND USE THEREOF IN COSMETICS | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2018-12-27 | — | — | WO | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| US-20020006906-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES | 2002-01-17 | — | — | US | disclosed |
| EP-1147765-A1 | New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) | 2001-10-24 | — | — | EP | disclosed |
| WO-2001072262-A2 | NEW COSMETIC, PERSONAL CARE, CLEANING AGENT, AND NUTRITIONAL SUPPLEMENT COMPOSITIONS COMPRISING BIOACTIVE GLASS AND METHODS OF MAKING AND USING THE SAME | SCHOTT GLAS (DE) | 2001-10-04 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030185784-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven nonwoven supports | CUTA, PLOD3, SOST | MAOA 1824/4885MAOB 2794/4885MAPKAPK2 2212/4885 |
| US-20020006906-A1 | Novel active agent, composition containing it and use in the cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical field or on woven or nonwoven supports | CUTA, PLOD3, SOST | MAOA 1972/4885MAOB 3006/4885MAPKAPK2 2406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.